158 related articles for article (PubMed ID: 36469109)
1. Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carcinoma cell line (A549).
Mohamed MF; Ibrahim NS; Saddiq AA; Almaghrabi OA; Al-Hazemi ME; Hassaneen HM; Abdelhamid IA
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):719-736. PubMed ID: 36469109
[TBL] [Abstract][Full Text] [Related]
2. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of novel 3-(furan-2-yl)pyrazolyl and 3-(thiophen-2-yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies.
Helmy MT; Sroor FM; Mahrous KF; Mahmoud K; Hassaneen HM; Saleh FM; Abdelhamid IA; Mohamed Teleb MA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100381. PubMed ID: 34939695
[TBL] [Abstract][Full Text] [Related]
4. Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.
Wang Y; Hedblom A; Koerner SK; Li M; Jernigan FE; Wegiel B; Sun L
Bioorg Med Chem Lett; 2016 Dec; 26(23):5703-5706. PubMed ID: 27810244
[TBL] [Abstract][Full Text] [Related]
5. A Novel Tetramethylpyrazine Chalcone Hybrid- HCTMPPK, as a Potential Anti-Lung Cancer Agent by Downregulating MELK.
Ma Y; Cui Q; Zhu W; Wang M; Zhai L; Hu W; Liu D; Liu M; Li Y; Li M; Han W
Drug Des Devel Ther; 2024; 18():1531-1546. PubMed ID: 38737331
[TBL] [Abstract][Full Text] [Related]
6. A New Series of Pyrrole-Based Chalcones: Synthesis and Evaluation of Antimicrobial Activity, Cytotoxicity, and Genotoxicity.
Özdemir A; Altıntop MD; Sever B; Gençer HK; Kapkaç HA; Atlı Ö; Baysal M
Molecules; 2017 Nov; 22(12):. PubMed ID: 29189730
[TBL] [Abstract][Full Text] [Related]
7. Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents
Su Q; Xu B; Tian Z; Gong Z
Acta Pharm; 2022 Sep; 72(3):389-402. PubMed ID: 36651540
[TBL] [Abstract][Full Text] [Related]
8. Novel [l,2,4]triazolo[3,4-a]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis.
Mohamed MF; Sroor FM; Ibrahim NS; Salem GS; El-Sayed HH; Mahmoud MM; Wagdy MM; Ahmed AM; Mahmoud AT; Ibrahim SS; Ismail MM; Eldin SM; Saleh FM; Hassaneen HM; Abdelhamid IA
Invest New Drugs; 2021 Feb; 39(1):98-110. PubMed ID: 32856275
[TBL] [Abstract][Full Text] [Related]
9. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
10. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
11. New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells.
Ahmed FF; Abd El-Hafeez AA; Abbas SH; Abdelhamid D; Abdel-Aziz M
Eur J Med Chem; 2018 May; 151():705-722. PubMed ID: 29660690
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
13. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
15. Novel indolyl-chalcone derivatives inhibit A549 lung cancer cell growth through activating Nrf-2/HO-1 and inducing apoptosis in vitro and in vivo.
Zhao X; Dong W; Gao Y; Shin DS; Ye Q; Su L; Jiang F; Zhao B; Miao J
Sci Rep; 2017 Jun; 7(1):3919. PubMed ID: 28634389
[TBL] [Abstract][Full Text] [Related]
16. The synthetic chalcone derivative 2-hydroxy-3',5,5'-trimethoxychalcone induces unfolded protein response-mediated apoptosis in A549 lung cancer cells.
Gil HN; Koh D; Lim Y; Lee YH; Shin SY
Bioorg Med Chem Lett; 2018 Sep; 28(17):2969-2975. PubMed ID: 30017320
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and bioevaluation of novel prenylated chalcones derivatives as potential antitumor agents.
Yu J; Wang X; Cheng S; Zeng X; Wan X; Wei S; Xu B; Luo H; Meng X
Eur J Pharm Sci; 2024 Jan; 192():106660. PubMed ID: 38052256
[TBL] [Abstract][Full Text] [Related]
18. A flavonoid isolated from Streptomyces sp. (ERINLG-4) induces apoptosis in human lung cancer A549 cells through p53 and cytochrome c release caspase dependant pathway.
Balachandran C; Sangeetha B; Duraipandiyan V; Raj MK; Ignacimuthu S; Al-Dhabi NA; Balakrishna K; Parthasarathy K; Arulmozhi NM; Arasu MV
Chem Biol Interact; 2014 Dec; 224():24-35. PubMed ID: 25289772
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
20. Novel Tetrahydro-[1,2,4]triazolo[3,4-
Darwish MIM; Moustafa AM; Youssef AM; Mansour M; Yousef AI; El Omri A; Shawki HH; Mohamed MF; Hassaneen HM; Abdelhamid IA; Oishi H
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
